Evaluating the Clinical Utility of Genomic Variants Derived from Next-Generation Sequencing for Opportunistic Disease Screening and Risk Assessment: Evidence Gaps and Priorities
Keyword(s):
2020 ◽
Vol 61
(11)
◽
pp. 2568-2583
◽
2015 ◽
Vol 31
(1)
◽
pp. 62-70
◽
Keyword(s):
2019 ◽
Vol 18
◽
pp. 18-26
◽
2015 ◽
Vol 33
(15_suppl)
◽
pp. e22127-e22127
2018 ◽
Vol 36
(15_suppl)
◽
pp. e24199-e24199
2016 ◽
Vol 26
(1)
◽
pp. 105-112
◽
2014 ◽
Vol 23
(4)
◽
pp. 633-639
◽